Resnicow K, Futterman R, Weston RE.
et al. Smoking prevalence in Harlem, New York. Am J Health Promot.1996;10:343-346.
Ahluwalia JS, McNagny SE. Smoking prevalence and desire to quit in inner city African American
walk in clinic patients. Clin Res.1993;41:752A.
Giovino GA, Schooley MW, Zhu BP.
et al. Surveillance for selected tobacco-use behaviors—United States,
1900-1994. Mor Mortal Wkly Rep CDC Surveill Summ.1994;43:1-43
Fiore MC, Novotny TE, Pierce JP, Hatziandreu EJ, Patel KM, Davis RM. Trends in cigarette smoking in the U. S.—the changing influence
of gender and race. JAMA.1989;261:49-55.
Hahn LP, Folsom AR, Sprafka JM, Norsted SW. Cigarette smoking and cessation behaviors among urban blacks and whites. Public Health Rep.1990;105:290-295.
Royce JM, Hymowitz N, Corbett K, Hartwell TD, Orlandi MA.for the COMMIT Research group. Smoking cessation factors among African Americans and whites. Am J Public Health.1993;83:220-226.
Hurt RD, Sachs DP, Glover ED.
et al. A comparison of sustained-release bupropion and placebo for smoking
cessation. N Engl J Med.1997;337:1195-1202.
Jorenby DE, Leischow SJ, Nides MA.
et al. A controlled trial of sustained-release bupropion, a nicotine patch,
or both for smoking cessation. N Engl J Med.1999;340:685-691.
Kabat GC, Morabia A, Wynder EL. Comparison of smoking habits of blacks and whites in a case-control
study. Am J Public Health.1991;81:1483-1486.
Caraballo RS, Giovino GA, Pechacek TF.
et al. Racial and ethnic differences in serum continine levels of adult cigarette
smokers: Third National Health and Nutrition Examination Survey, 1988-1991. JAMA.1998;280:135-139.
Perez-Stable EJ, Herrera B, Jacob III P, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA.1998;280:152-156.
US Department of Health and Human Services. Healthy People 2010. Washington, DC: US Dept Health and Human Services; 2000.
Robinson RG, Orleans CT, James DA, Sutton CD. Pathways to Freedom: Winning the Fight Against Tobacco. Philadelphia, Pa: Fox Chase Cancer Center; 1992.
Harris KJ, Ahluwalia JS, Okuyemi KS.
et al. Addressing cultural sensitivity in a smoking cessation intervention:
development of the Kick It at Swope project. J Community Psychol.2001;29:447-458.
Harris KJ, Ahluwalia JS, Catley D, Okuyemi KS, Mayo M. Recruiting minorities into clinical trials. Nicotine Tob Res.In press.
Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change
Addictive Behavior. New York, NY: Guilford Press; 1991.
Turner J, Catley D, Harris K.
et al. The importance of motivational interviewing in a smoking cessation
program for African Americans. In: Program and abstracts of the 6th Annual Meeting of the Society
for Research on Nicotine and Tobacco; February 18-20, 2000; Arlington, Va.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom
Tolerance Questionnaire. Br J Addict.1991;86:1119-1127.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry.1986;43:289-294.
Weissman MM, Sholomakas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation
study. Am J Epidemiol.1977;106:203-214.
Not Available. SAS/STAT User's Guide, Version 8 [computer program]. Cary, NC: SAS Institute Inc; 1999.
Ahluwalia JS, McNagny SE, Clark WS. Smoking cessation among inner-city African Americans using the nicotine
transdermal patch. J Gen Intern Med.1998;13:1-8.
Hughes JR, Gust SW, Keenan RM, Fenwick JW, Healey ML. Nicotine vs placebo gum in general medical practice. JAMA.1989;261:1300-1305.
Fagerstrom KO. Effects of nicotine chewing gum and follow up appointments in physician
based smoking cessation. Prev Med.1984;13:517-527.
Hurt RD, Dale LC, Fredrickson PA.
et al. Nicotine patch therapy for smoking cessation combined with physician
advice and nurse follow-up. JAMA.1994;271:595-600.
Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled
clinical trial. Prev Med.1995;24:41-47.
Sachs DP, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical
practice setting, without intensive group counseling. Arch Intern Med.1993;153:1881-1890.
Russell MA, Stapleton JA, Feyerabend C.
et al. Targeting heavy smokers in general practice: randomised controlled
trial of transdermal nicotine patches. BMJ.1993;306:1308-1312.
Tonnesen P, Norregaard J, Simonsen K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking
cessation. N Engl J Med.1991;325:311-315.
Hjalmarson AI. Effect of nicotine chewing gum in smoking cessation: a randomized placebo-controlled
double blind study. JAMA.1984;252:2835-2838.
Fee WM, Stewart MJ. A controlled trial of nicotine chewing gum in a smoking withdrawal
Hall SM, Delucchi KL, Velicer WF.
et al. Statistical analysis of randomized trials in tobacco treatment: longitudinal
designs with dichotomous outcome. Nicotine Tob Res.2001;3:193-202.
Lipsitz SR, Molenberghs G, Fitzmaurice GM, Ibrahim J. GEE with Gaussian estimation of the correlations when data are incomplete. Biometrics.2000;56:528-536.
Littell RC, Pendergast J, Natarajan R. Modelling covariance structure in the analysis of repeated measures
data. Stat Med.2000;19:1793-1819.
Romano PS, Bloom J, Syme SL. Smoking, social support, and hassles in an urban African-American community. Am J Public Health.1991;81:1415-1422.
Etter JF, Duc TV, Perneger TV. Validity of the Fagerstrom test for nicotine dependence and of the
Heaviness of Smoking Index among relatively light smokers. Addiction.1999;94:269-281.
Okuyemi KS, Ahluwalia JS, Ebersole-Robinson M, Mayo MS. Correlates of smoking menthol cigarettes among African Americans. In: Program and abstracts of the 8th Annual Meeting of the Society
for Research on Nicotine and Tobacco; February 23, 2002; Savannah, Ga.
Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: the National Health
and Nutrition Examination Surveys, 1960 to 1991. JAMA.1994;272:205-211.
Keil JE, Sutherland SE, Knapp RG, Lackland DT, Gazes PC, Tyroler HA. Mortality rates and risk factors for coronary disease in black as compared
with white men and women. N Engl J Med.1993;329:73-78.
Dale LC, Glover ED, Sach DPL.
et al. Bupropion for smoking cessation: predictors of successful outcome. Chest.2001;119:1357-1364.
Shiffman S, Johnston JA, Khayrallah M.
et al. The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology.2000;148:33-40.